HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-AUG-12 3VW8 TITLE CRYSTAL STRUCTURE OF HUMAN C-MET KINASE DOMAIN WITH ITS INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1024-1352; COMPND 5 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER COMPND 6 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.MATSUMOTO,N.MIYAMOTO,T.HIRAYAMA,H.OKI,K.OKADA,M.TAWADA,H.IWATA, AUTHOR 2 H.MIKI,K.NAKAMURA,A.HORI,S.IMAMURA REVDAT 3 24-AUG-22 3VW8 1 JRNL REMARK SEQADV REVDAT 2 04-DEC-13 3VW8 1 JRNL REVDAT 1 14-AUG-13 3VW8 0 JRNL AUTH S.MATSUMOTO,N.MIYAMOTO,T.HIRAYAMA,H.OKI,K.OKADA,M.TAWADA, JRNL AUTH 2 H.IWATA,K.NAKAMURA,S.YAMASAKI,H.MIKI,A.HORI,S.IMAMURA JRNL TITL STRUCTURE-BASED DESIGN, SYNTHESIS, AND EVALUATION OF JRNL TITL 2 IMIDAZO[1,2-B]PYRIDAZINE AND IMIDAZO[1,2-A]PYRIDINE JRNL TITL 3 DERIVATIVES AS NOVEL DUAL C-MET AND VEGFR2 KINASE JRNL TITL 4 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 21 7686 2013 JRNL REFN ESSN 1464-3391 JRNL PMID 24216091 JRNL DOI 10.1016/J.BMC.2013.10.028 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 17015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 926 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1180 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.18 REMARK 3 BIN R VALUE (WORKING SET) : 0.2790 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.2960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2414 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.77000 REMARK 3 B22 (A**2) : 6.35000 REMARK 3 B33 (A**2) : -2.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.286 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.162 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.053 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2510 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1708 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3398 ; 1.122 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4164 ; 0.826 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 299 ; 5.145 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 105 ;33.526 ;23.524 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 432 ;13.166 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;15.998 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 375 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2715 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 509 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1508 ; 0.564 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 608 ; 0.094 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2446 ; 1.043 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1002 ; 1.384 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 952 ; 2.280 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3VW8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000095577. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23931 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 25% PEG2000, 8% REMARK 280 ISOPROPANOL, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.34500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.98450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.39300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.98450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.34500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.39300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1041 REMARK 465 ASP A 1042 REMARK 465 ILE A 1043 REMARK 465 SER A 1044 REMARK 465 SER A 1045 REMARK 465 PRO A 1046 REMARK 465 LEU A 1047 REMARK 465 LEU A 1048 REMARK 465 GLN A 1049 REMARK 465 ASN A 1050 REMARK 465 THR A 1051 REMARK 465 VAL A 1052 REMARK 465 HIS A 1053 REMARK 465 ILE A 1054 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ASP A 1286 REMARK 465 VAL A 1287 REMARK 465 ASN A 1288 REMARK 465 THR A 1289 REMARK 465 PHE A 1290 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 1264 O HOH A 1580 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD2 LEU A 1056 O HOH A 1608 2554 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A1082 78.01 -116.09 REMARK 500 ARG A1203 -15.73 80.47 REMARK 500 ASP A1204 46.62 -147.35 REMARK 500 ALA A1221 -169.12 -161.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DF6 A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1402 DBREF 3VW8 A 1025 1352 UNP P08581 MET_HUMAN 1024 1352 SEQADV 3VW8 A UNP P08581 ALA 1057 DELETION SEQRES 1 A 328 VAL GLN TYR PRO LEU THR ASP MET SER PRO ILE LEU THR SEQRES 2 A 328 SER GLY ASP SER ASP ILE SER SER PRO LEU LEU GLN ASN SEQRES 3 A 328 THR VAL HIS ILE ASP LEU SER LEU ASN PRO GLU LEU VAL SEQRES 4 A 328 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 5 A 328 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 6 A 328 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 7 A 328 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 8 A 328 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 9 A 328 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 10 A 328 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 11 A 328 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 12 A 328 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 13 A 328 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 14 A 328 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 15 A 328 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 16 A 328 VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS SEQRES 17 A 328 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 18 A 328 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 19 A 328 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 20 A 328 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 21 A 328 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 22 A 328 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 23 A 328 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 24 A 328 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 25 A 328 ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU HIS TYR SEQRES 26 A 328 VAL HIS VAL HET DF6 A1401 34 HET CL A1402 1 HETNAM DF6 N-({4-[(6,7-DIMETHOXYQUINOLIN-4-YL) HETNAM 2 DF6 OXY]PHENYL}CARBAMOTHIOYL)-2-PHENYLACETAMIDE HETNAM CL CHLORIDE ION FORMUL 2 DF6 C26 H23 N3 O4 S FORMUL 3 CL CL 1- FORMUL 4 HOH *143(H2 O) HELIX 1 1 ASN A 1059 HIS A 1068 1 10 HELIX 2 2 ASP A 1117 ILE A 1130 1 14 HELIX 3 3 MET A 1131 PHE A 1134 5 4 HELIX 4 4 ASP A 1164 ASN A 1171 1 8 HELIX 5 5 THR A 1177 LYS A 1198 1 22 HELIX 6 6 ALA A 1206 ARG A 1208 5 3 HELIX 7 7 PHE A 1223 ARG A 1227 5 5 HELIX 8 8 ASP A 1228 TYR A 1235 5 8 HELIX 9 9 PRO A 1246 MET A 1250 5 5 HELIX 10 10 ALA A 1251 GLN A 1258 1 8 HELIX 11 11 THR A 1261 THR A 1278 1 18 HELIX 12 12 ILE A 1292 GLN A 1298 1 7 HELIX 13 13 PRO A 1309 TRP A 1320 1 12 HELIX 14 14 LYS A 1323 ARG A 1327 5 5 HELIX 15 15 SER A 1329 THR A 1343 1 15 SHEET 1 A 6 VAL A1070 ILE A1071 0 SHEET 2 A 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 A 6 LEU A1154 PRO A1158 -1 O VAL A1156 N GLY A1144 SHEET 4 A 6 LYS A1104 LEU A1112 -1 N ALA A1108 O LEU A1157 SHEET 5 A 6 GLY A1090 LEU A1098 -1 N TYR A1093 O VAL A1109 SHEET 6 A 6 LEU A1076 ARG A1086 -1 N ILE A1077 O THR A1096 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SITE 1 AC1 17 ILE A1084 ALA A1108 LYS A1110 GLU A1127 SITE 2 AC1 17 ILE A1130 MET A1131 LEU A1140 LEU A1157 SITE 3 AC1 17 PRO A1158 TYR A1159 MET A1160 GLY A1163 SITE 4 AC1 17 HIS A1202 MET A1211 ALA A1221 ASP A1222 SITE 5 AC1 17 PHE A1223 SITE 1 AC2 5 LYS A1179 PHE A1344 GLY A1346 GLU A1347 SITE 2 AC2 5 HIS A1348 CRYST1 42.690 78.786 89.969 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023425 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012693 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011115 0.00000